Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tony Andreas Müller"'
Autor:
Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, Alicja Pacholewska, Christoph Markus Aszyk, Francien Grotenhuijs, Tony Andreas Müller, Ozlem Onder, Prerana Wagle, Carmen Diana Herling, Maria Kleppe, Zhefang Wang, Kevin R. Coombes, Sandra Robrecht, Priya S. Dalvi, Bianca Andra Lungu, Petra Mayer, Lynne V. Abruzzo, Janine Altmüller, Birgit Sybille Gathof, Thorsten Persigehl, Kirsten Fischer, Billy Michael Chelliah Jebaraj, Hugh Young Rienhoff, Rupert C. Ecker, Yue Zhao, Christiane Josephine Bruns, Stephan Stilgenbauer, Kojo S. J. Elenitoba-Johnson, Michael Hallek, Michal R. Schweiger, Margarete Odenthal, Elena Vasyutina, Marco Herling
Publikováno v:
Blood.
In chronic lymphocytic leukemia (CLL), epigenetic alterations are considered to centrally shape the transcriptional signatures that drive disease evolution and that underlie its biological and clinical subsets. Characterizations of epigenetic regulat
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Table from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c141b2d3e7d1971ae177a13a3a23f6
https://doi.org/10.1158/0008-5472.22431076.v1
https://doi.org/10.1158/0008-5472.22431076.v1
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Figure from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029066d721fddd13077ebd47940ba924
https://doi.org/10.1158/0008-5472.22431088
https://doi.org/10.1158/0008-5472.22431088
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-refractory T-cell malignancy with limited therapeutic options and a poor prognosis. Current disease concepts implicate TCL1A oncogene-mediated enhanced T-cell receptor (TCR) signaling and aberr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dd110a0b3042fa1db8767a1a42fc5d
https://doi.org/10.1158/0008-5472.c.6513796
https://doi.org/10.1158/0008-5472.c.6513796
Autor:
Marco Herling, Alexandra Schrader, Stefan Hüttelmaier, Daniel Auguin, Michael Hallek, Janine Altmüller, Birgit Gathof, Marek Franitza, Katharina Ommer, Markus Glaß, Linus Wahnschaffe, Tony Andreas Müller, Moritz Otte, Sebastian Oberbeck, Nadine Bley, Johanna Stachelscheid, Till Braun
Supplementary Data from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20848ccac394de23658001a58486f8dd
https://doi.org/10.1158/0008-5472.22431091
https://doi.org/10.1158/0008-5472.22431091
Autor:
Till Braun, Johanna Stachelscheid, Nadine Bley, Sebastian Oberbeck, Moritz Otte, Tony Andreas Müller, Linus Wahnschaffe, Markus Glaß, Katharina Ommer, Marek Franitza, Birgit Gathof, Janine Altmüller, Michael Hallek, Daniel Auguin, Stefan Hüttelmaier, Alexandra Schrader, Marco Herling
Publikováno v:
Cancer Research. 82:1818-1831
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-refractory T-cell malignancy with limited therapeutic options and a poor prognosis. Current disease concepts implicate TCL1A oncogene-mediated enhanced T-cell receptor (TCR) signaling and aberr
Autor:
Tobias Suske, Helena Sorger, Frank Ruge, Nicole Prutsch, Mark W. Zimmerman, Thomas Eder, Barbara Maurer, Christina Wagner, Susann Schönefeldt, Katrin Spirk, Alexander Pichler, Tea Pemovska, Carmen Schweicker, Daniel Pölöske, Dennis Jungherz, Tony Andreas Müller, Myint Myat Khine Aung, Ha Thi Thanh Pham, Kerstin Zimmel, Thomas Krausgruber, Christoph Bock, Mathias Müller, Maik Dahlhoff, Auke Boersma, Thomas Rülicke, Roman Fleck, Patrick Thomas Gunning, Tero Aittokallio, Satu Mustjoki, Takaomi Sanda, Sylvia Hartmann, Florian Grebien, Gregor Hoermann, Torsten Haferlach, Philipp Bernhard Staber, Heidi Anne Neubauer, Alfred Thomas Look, Marco Herling, Richard Moriggl
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive immature T-cell cancer. Hotspot mutations in JAK-STAT pathway membersIL7R,JAK1andJAK3were analyzed in depth. However, the role ofSTAT5AorSTAT5Bmutations promoting their hyperactivation is p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8977e2bbb46966ed8c17213376c7212a
https://doi.org/10.1101/2022.12.21.519945
https://doi.org/10.1101/2022.12.21.519945
Bringing Independence and Accountability Together: Mission Impossible for the European Central Bank?
Autor:
Eugénia C. Heldt, Tony Andreas Müller
Publikováno v:
Journal of European Integration. 44:837-853
The European Central Bank’s (ECB) role as a political actor during the euro crisis raised concerns about its independence and insufficient accountability. Against this backdrop, the article investi...
Autor:
Sivahari Prasad Gorantla, Michael Rassner Rassner, Tony Andreas Müller, Teresa Poggio, Kirstyn Anne Crossley, Anna-Lena Denecke, Kornelia R Fritsch, Geoffroy Andrieux, Helen Kleinfelder, Shifa Khaja Saleem, Sudheer Madan Mohan Gambheer, Irene Gonzalez Menendez, Detlef Bentrop, Rainer Trittler, Svetlana Rylova, Dietmar Pfeifer, Leticia Quintanilla Martinez, Christine Dierks, Robert Zeiser, Anna Lena Illert, Nikolas von Bubnoff, Justus Duyster
Publikováno v:
Cancer Research. 83:4497-4497
Ruxolitinib (Jakavi) is a potent JAK1/JAK2 specific inhibitor, approved for the treatment of myeloproliferative neoplasia (MPN) such as primary myelofibrosis (PMF) and polycythemia Vera (PV). The primary clinical benefit of ruxolitinib in MPN patient
Autor:
Robert A.J. Oostendorp, Michael Rassner, Helen Kleinfelder, Dietmar Pfeifer, Jan Mitschke, Justus Duyster, Cornelius Miething, Miguel Waterhouse, Lena Jakob, Tony Andreas Müller, Pia Veratti
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11649, p 11649 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences
Volume 22
Issue 21
The IL-6 family cytokine Oncostatin M (OSM) is involved in cell development, growth, hematopoiesis, inflammation, and cancer. Intriguingly, OSM has proliferative and antiproliferative effects depending on the target cell. The molecular mechanisms und